VEVAURA
LIVE

Serial Number

79244180

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 7, 2018

Add to watchlist:

No watchlists yet
View on USPTO

VEVAURA Trademark

Serial Number: 79244180 • Registration: 5911018

VEVAURA is a trademark filed by NOVARTIS AG on September 7, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 7, 2018

Registration Date

November 19, 2019

Published for Opposition

September 3, 2019

Cancellation Date

December 15, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 2, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 2, 2023 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 17, 2020 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Mar 13, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 13, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 19, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 30, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 14, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 14, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2019 NONP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 30, 2019 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 29, 2019 RCCK
ASSIGNED TO LIE
Jun 14, 2019 ALIE
REFUSAL PROCESSED BY IB
Dec 21, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 1, 2018 RFCS
REFUSAL PROCESSED BY MPU
Nov 30, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2018 RFCR
SUSPENSION LETTER WRITTEN
Nov 15, 2018 CNSL
ASSIGNED TO EXAMINER
Nov 13, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 10, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 5, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 1, 2018 REPR